Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas

Clinical trial NCT00647764 · COMPLETED

Trial details

NCT number: NCT00647764
Sponsor: Esanex Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Malignancy Lymphoid Malignancy (Lymphoma and CLL)Leukemia Lymphoma

Start date: 2008-03-01
Primary completion: 2010-09-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.